The expression of IL-6 was significantly downregulated following treatment with DAH and SOR either alone or in combination, with the highest expression in the HCC + SOR + DAH group followed by the HCC + SOR group and lowest expression in HCC + DAH group, as compared with the HCC untreated group. Here, IL6 is linked to hepatocellular carcinoma.